Suraksha Diagnostic IPO Details
IPO Issue Open Date: | 29 November, 2024 |
IPO Issue Close Date: | 3 December, 2024 |
IPO Issue Price Band: | ₹420 to ₹441 Per Share |
Face Value: | ₹2 Per Equity Share |
IPO Issue Size: | ₹846.25 Crores | 1,91,89,330 shares |
Fresh Issue: | ₹[.] Crores | 1,91,89,330 shares |
Offer for Sale: | ₹[.] Crores |
Issue Type: | Book Built Issue |
IPO Listing At: | NSE |
IPO Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Employee Discount: | ₹[.] per share |
Suraksha Diagnostic IPO Prospectus:
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Suraksha Diagnostic IPO Dates Timeline
Issue Open Date: | 29 November, 2024 |
Issue Close Date: | 3 December, 2024 |
Basis of Allotment Date: | 4 December, 2024 |
Refunds Initiation: | 5 December, 2024 |
Shares Credit in Demat: | 5 December, 2024 |
IPO Listing Date Detail: | 6 December, 2024 |
Suraksha Diagnostic IPO Market Lot
Application | Lot Size, Shares and Price Details |
Retail (Min) | 1 lots and 34 shares = ₹14,994 |
Retail (Max) | 13 lots and 442 shares = ₹1,94,922 |
HNI (Min) | 14 lots and 476 shares = ₹2,09,916 |
B-HNI Minimum | 67 lots and 2,278 shares = ₹1,004,598 |
Suraksha Diagnostic IPO GMP*
GMP Date | GMP Today | Subject to Sauda | Kostak | Expected Gain |
Today | ₹10 | ₹- | ₹- | 2% |
4 Dec | ₹2 | ₹- | ₹- | 0% |
About Suraksha Diagnostic
To be Updated Soon
Suraksha Diagnostic IPO Strengths
- Track record of profitability and consistent financial performance
- Management team with relevant industry experience
- Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and
- medical consultation services
Objects of the IPO Issue
- To carry out the Offer for Sale of up to 19,189,330 Equity Shares of face value ₹ 2 each aggregating to ₹ [●] million by the Selling Shareholders; and
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Suraksha Diagnostic Company Financial Report
The company reported revenue of ₹218.71 crores in 2024 against ₹190.13 crores in 2023. The company reported a profit of ₹23.13 crores in 2024 against a Profit of ₹6.07 crores in 2023.
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹223.19 | ₹197.76 | ₹20.82 | ₹275.96 |
2023 | ₹190.13 | ₹186.94 | ₹6.07 | ₹281.20 |
2024 | ₹218.71 | ₹190.03 | ₹23.13 | ₹300.21 |
Suraksha Diagnostic IPO Valuation – Key Performance Indicator
KPI as of March 31, 2024.
KPI | Values |
ROE: | 14.09% |
ROCE: | 21.46% |
EBITDA Margin: | 33.66% |
PAT Margin: | 10.57% |
Debt to equity ratio: | 0.20 |
Earning Per Share (EPS): | ₹4.43 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 14.09% |
Net Asset Value (NAV): | ₹33.66 |
Peer Group Comparison
The below peer comparison table’s data are showing as per the DRHP and RHP.
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Dr Lal PathLabs | 43.05 | 68.66 | 20.35 | 221.47 | 2226.60 Cr. |
Metropolis Healthcare | 24.95 | 82.57 | 12.26 | 213.98 | 1207.71 Cr. |
Thyrocare | 13.42 | 47.60 | 13.34 | 99.48 | 571.88 Cr. |
Vijaya Diagnostic | 11.62 | 67.65 | 19.77 | 64.21 | 547.81 Cr. |
Suraksha Diagnostic IPO Registrar
KFin Technologies Limited
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Phone: +91 40 6716 2222
E-mail: sdl.ipo@kfintech.com
Website: www.kfintech.com
Suraksha Diagnostic IPO Lead Manager
- Nuvama Wealth and Investment Limited
Suraksha Diagnostic IPO allotment status check on Link Intime website. Click on Kfin Technologies to get allotment status.
Promoters of Suraksha Diagnostic
- Dr. Somnath Chatterjee
- Ms. Ritu Mittal
- Mr. Satish Kumar Verma
Company Address
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327,
New Town, Rajarhat, Kolkata 700 156, West Bengal, India
Phone: +91 33 66059750
Email: investors@surakshanet.com
Website: www.surakshanet.com